Shinhan Financial Group is partnering with the Korea Technology Finance Corporation and Seoul National University Hospital to jointly foster bio venture companies that will expand into overseas markets.

On the 26th in San Diego, USA, at the "Global K-Bio Venture Companies Joint Discovery and Nurturing Business Agreement Ceremony," (from left) Hosik Jang, Head of CIB Group at Shinhan Bank, Seonggeun Kwon, Deputy Director of Research at Seoul National University Hospital, and Changho Chun, Standing Director at Korea Technology Finance Corporation, are taking a commemorative photo. Provided by Shinhan Financial Group

On the 26th in San Diego, USA, at the "Global K-Bio Venture Companies Joint Discovery and Nurturing Business Agreement Ceremony," (from left) Hosik Jang, Head of CIB Group at Shinhan Bank, Seonggeun Kwon, Deputy Director of Research at Seoul National University Hospital, and Changho Chun, Standing Director at Korea Technology Finance Corporation, are taking a commemorative photo. Provided by Shinhan Financial Group

View original image

In this regard, Shinhan Financial Group announced on the 29th that it signed a "Global K-Bio Venture Companies Joint Discovery and Cultivation Business Agreement" with the Korea Technology Finance Corporation and Seoul National University Hospital in San Diego, USA, on the 26th.


The three organizations, who attended the "K-Bio Global Innovation Forum" held locally, pursued this agreement to expand investment attraction and technological cooperation for domestic bio venture companies and to establish a foundation for their global expansion.


Under this agreement, the three organizations will combine their expertise to support jointly discovered bio venture companies through Shinhan Financial Group's investments and loans, guarantee support from the Korea Technology Finance Corporation, and R&D infrastructure and technical assistance from Seoul National University Hospital. They plan to build a collaborative platform that covers the entire growth cycle, from technology commercialization to consulting for overseas market entry and network connections.



A Shinhan Financial Group official stated, "We will continue to actively support the growth and global expansion of K-Bio venture companies to enhance the industry's competitiveness."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing